ENDOR AG/ DE0005491666 /
7/30/2024 8:04:54 AM | Chg. -0.132 | Volume | Bid11:06:23 AM | Ask11:06:23 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.314EUR | -29.60% | 0 Turnover: 0.000 |
0.322Bid Size: 680 | 0.540Ask Size: 1,920 | 6.66 mill.EUR | - | 2.15 |
GlobeNewswire
3/28
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
5/1/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
4/28/2020
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.
GlobeNewswire
4/24/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
4/17/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Inv...
GlobeNewswire
3/2/2020
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business ...
GlobeNewswire
1/16/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
GlobeNewswire
1/16/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies